- Home
- SNGX vs PLAG Comparison
SNGX vs PLAG Comparison
Compare SNGX & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- PLAG
- Stock Information
- Founded
- SNGX 1987
- PLAG 1986
- Country
- SNGX United States
- PLAG United States
- Employees
- SNGX N/A
- PLAG N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- PLAG Packaged Foods
- Sector
- SNGX Health Care
- PLAG Consumer Staples
- Exchange
- SNGX Nasdaq
- PLAG Nasdaq
- Market Cap
- SNGX 6.5M
- PLAG 6.6M
- IPO Year
- SNGX 1987
- PLAG N/A
- Fundamental
- Price
- SNGX $1.37
- PLAG $0.82
- Analyst Decision
- SNGX
- PLAG
- Analyst Count
- SNGX 0
- PLAG 0
- Target Price
- SNGX N/A
- PLAG N/A
- AVG Volume (30 Days)
- SNGX 147.3K
- PLAG 856.5K
- Earning Date
- SNGX 08-08-2025
- PLAG 08-13-2025
- Dividend Yield
- SNGX N/A
- PLAG N/A
- EPS Growth
- SNGX N/A
- PLAG N/A
- EPS
- SNGX N/A
- PLAG N/A
- Revenue
- SNGX $2,342.00
- PLAG $6,066,143.00
- Revenue This Year
- SNGX N/A
- PLAG N/A
- Revenue Next Year
- SNGX N/A
- PLAG N/A
- P/E Ratio
- SNGX N/A
- PLAG N/A
- Revenue Growth
- SNGX N/A
- PLAG N/A
- 52 Week Low
- SNGX $1.31
- PLAG $0.47
- 52 Week High
- SNGX $14.83
- PLAG $5.52
- Technical
- Relative Strength Index (RSI)
- SNGX 23.71
- PLAG 34.81
- Support Level
- SNGX $1.31
- PLAG $0.75
- Resistance Level
- SNGX $1.95
- PLAG $0.92
- Average True Range (ATR)
- SNGX 0.07
- PLAG 0.44
- MACD
- SNGX -0.05
- PLAG -0.21
- Stochastic Oscillator
- SNGX 9.56
- PLAG 14.28
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.